"Receptors, Dopamine D1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES.
| Descriptor ID |
D017447
|
| MeSH Number(s) |
D12.776.543.750.670.300.400.400 D12.776.543.750.695.150.400.400 D12.776.543.750.720.330.400.400
|
| Concept/Terms |
Receptors, Dopamine D1- Receptors, Dopamine D1
- Dopamine-D1 Receptor
- Dopamine D1 Receptor
- Receptor, Dopamine-D1
- Dopamine D1 Receptors
- D1 Receptors, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Dopamine D1".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Dopamine [D12.776.543.750.670.300.400]
- Receptors, Dopamine D1 [D12.776.543.750.670.300.400.400]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Dopamine [D12.776.543.750.695.150.400]
- Receptors, Dopamine D1 [D12.776.543.750.695.150.400.400]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Dopamine [D12.776.543.750.720.330.400]
- Receptors, Dopamine D1 [D12.776.543.750.720.330.400.400]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Dopamine D1".
This graph shows the total number of publications written about "Receptors, Dopamine D1" by people in this website by year, and whether "Receptors, Dopamine D1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 3 | 0 | 3 |
| 2003 | 2 | 2 | 4 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 4 | 1 | 5 |
| 2007 | 5 | 0 | 5 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 1 | 2 | 3 |
| 2013 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Dopamine D1" by people in Profiles.
-
Social setting interacts with hyper dopamine to boost the stimulant effect of ethanol. Addict Biol. 2024 06; 29(6):e13420.
-
Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia. Nat Commun. 2021 06 09; 12(1):3478.
-
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders. Nat Commun. 2021 06 09; 12(1):3495.
-
Spinal Dopaminergic Mechanisms Regulating the Micturition Reflex in Male Rats with Complete Spinal Cord Injury. J Neurotrauma. 2021 03 15; 38(6):803-817.
-
Dopamine-based mechanism for transient forgetting. Nature. 2021 03; 591(7850):426-430.
-
Development of pyrimidone D1 dopamine receptor positive allosteric modulators. Bioorg Med Chem Lett. 2021 01 01; 31:127696.
-
Injection of D1 receptor antagonist SCH23390 into the periaqueductal gray attenuates morphine withdrawal symptoms in rats. Neurosci Lett. 2020 01 01; 714:134502.
-
Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters. Am J Physiol Renal Physiol. 2019 10 01; 317(4):F949-F956.
-
Dopamine Receptor DAMB Signals via Gq to Mediate Forgetting in Drosophila. Cell Rep. 2017 Nov 21; 21(8):2074-2081.
-
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. J Psychopharmacol. 2016 05; 30(5):428-35.